Although adult patients in our cohort exhibited significantly higher RIPK-1 levels than pediatric patients, the distribution of this biomarker across diagnostic categories was remarkably consistent—decreasing progressively through sepsis, SIRS, cardiac cases, and healthy controls in both age groups. Here, RIPK1 is linked to systemic inflammatory response syndrome.